Encompass Health (NYSE:EHC – Get Free Report) and CVS Health (NYSE:CVS – Get Free Report) are both large-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations and risk.
Volatility & Risk
Encompass Health has a beta of 0.74, indicating that its share price is 26% less volatile than the S&P 500. Comparatively, CVS Health has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500.
Profitability
This table compares Encompass Health and CVS Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Encompass Health | 10.01% | 18.08% | 8.22% |
| CVS Health | 1.18% | 13.12% | 3.95% |
Dividends
Earnings and Valuation
This table compares Encompass Health and CVS Health”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Encompass Health | $5.94 billion | 2.04 | $566.20 million | $6.14 | 19.96 |
| CVS Health | $402.07 billion | 0.28 | $1.77 billion | $3.78 | 23.24 |
CVS Health has higher revenue and earnings than Encompass Health. Encompass Health is trading at a lower price-to-earnings ratio than CVS Health, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
97.3% of Encompass Health shares are owned by institutional investors. Comparatively, 80.7% of CVS Health shares are owned by institutional investors. 1.8% of Encompass Health shares are owned by company insiders. Comparatively, 0.9% of CVS Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Analyst Recommendations
This is a breakdown of current ratings and price targets for Encompass Health and CVS Health, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Encompass Health | 0 | 1 | 5 | 1 | 3.00 |
| CVS Health | 0 | 1 | 22 | 0 | 2.96 |
Encompass Health currently has a consensus target price of $148.50, indicating a potential upside of 21.18%. CVS Health has a consensus target price of $107.24, indicating a potential upside of 22.07%. Given CVS Health’s higher possible upside, analysts clearly believe CVS Health is more favorable than Encompass Health.
Summary
Encompass Health beats CVS Health on 11 of the 18 factors compared between the two stocks.
About Encompass Health
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.
